The combinatorial analysis showed that HCC patients with high tumor stage and S100P expression had a significantly lower -5-year survival rate (Figure 3D) than high-tumor-stage HCC patients without S100P expression (P = 0.0026). The gene discussed is S100P; the disease is neoplasm.